WebApr 10, 2024 · Financial Performance. In 2024, Bio-Techne's revenue was $1.11 billion, an increase of 18.75% compared to the previous year's $931.03 million. Earnings were $272.05 million, an increase of 93.75%. Financial Statements. WebApr 6, 2024 · MINNEAPOLIS, April 5, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it that it has reached a significant milestone with more than 1,000 Ella™ automated immunoassay instruments now in the field. The achievement is a testament to the growing demand across scientific and clinical research sectors for a …

Is Now The Time To Put Bio-Techne (NASDAQ:TECH) On Your …

WebGet the latest BIO-TECHNE Corp (TECH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … Web1 day ago · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … dholera smart city images

BIO-TECHNE TO ACQUIRE NAMOCELL - PR Newswire

WebAug 6, 2024 · About Bio-Techne. Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors ... WebBio-Techne announces launch of Cultrex™ UltiMatrix BME to support organoid and pluripotent stem cell cultures. Learn More About Cultrex UltiMatrix. Bio-Techne announces ISO 9001-2015 certification for its … WebAbout Us. Bio-Techne are committed to empowering researchers in Life Science and Clinical Diagnostic. Our pages highlight the ethos of our brand, our drive for excellence and the role we play in corporate and social responsibility. We are also proud sponsors of science conferences and events around the world, take a look at our event pages for ... dholera smartest city in india